Desk›Healthcare› Abbott India Ltd
Abbott India Ltd
BSE 500488 · NSE ABBOTINDIA · ISIN INE358A01014 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹26,378.40
-0.46%
BSE close, 28 August 2026
₹56,052.26 cr
2.1 cr shares · Mid cap
₹13,708.70 cr
as published
34.7× · 15.92×
EPS ₹759.87 · BV ₹1,656.93
6,929.05 / 1,552.02
₹ cr, as filed
11
3 selected · 27%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -19.5% |
|---|---|
| Against 52-week low | +4.8% |
| Day change | -0.46% |
| Size band | Mid cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹759.87 |
|---|---|
| Price / earnings | 34.71× |
| Price / book | 15.92× |
| Book value — derived, price ÷ P/B | ₹1,656.93 |
| Return on equity | 45.86% |
| Operating margin | 32.96% |
| Net margin | 23.63% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 45.87%
- ROE as published
- 45.86%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 1,813.68 | 428.52 | 201.66 | 32.96% | 23.63% |
| Mar-26 · Q | 1,709.51 | 394.93 | 185.85 | 32.55% | 23.10% |
| FY25-26 | 6,929.05 | 1,552.02 | 730.36 | 31.46% | 22.40% |
Quarter on quarter
- Revenue, quarter on quarter
- +6.1%
- Net profit, quarter on quarter
- +8.5%
- Operating margin, quarter on quarter
- +41 bps
Disclosure profile 11 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| KMP | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| Newspaper Publication | 3 |
| AGM / EGM | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Trading Window | 1 |
| Procedural sub-total | 8 |
| Total | 11 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 98 trading days
11 filings · 3 selected · busiest 2026-08-04 and 2026-08-12
Filing rhythm · the twelve most recent
2026-08-042026-10-06
SelectedProcedural
Filings
11 in the window · 10 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
2 October 2026 ·
Newspaper Publication
Newspaper Advertisement - Special Window for Transfer and Dematerialization of Physical Securities.
Company Update / Newspaper Publication View filing →
-
28 September 2026 ·
Closure of Trading Window
Closure of Trading Window for declaration of Unaudited Financial Results of the Company for the quarter ending September 30, 2026.
Insider Trading / SAST / Closure of Trading Window View filing →
-
7 September 2026 ·
Resignation of Company Secretary / Compliance Officer
Resignation of Company Secretary and Compliance Officer of the Company.
Company Update / Resignation of Company Secretary / Compliance Officer View filing →
-
14 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results along with Consolidated Scrutinizer's Report for the 82nd Annual General Meeting held on August 13, 2026.
AGM/EGM / AGM View filing →
-
14 August 2026 ·
-
13 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 82nd Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
12 August 2026 ·
Unaudited Financial Results For The Quarter Ended June 30, 2026.
Unaudited financial results for the quarter ended June 30, 2026.
Result / Financial Results View filing →
-
12 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
4 August 2026 ·
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.
Abbott India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....
Board Meeting / Board Meeting View filing →
-
4 August 2026 ·
Newspaper Publication
Newspaper Advertisement - Special Window for Transfer and Dematerialization of Physical Securities
Company Update / Newspaper Publication View filing →
RSS feed for Abbott India Ltd · the 50 most recent filings